Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
Botulinum toxin A (BoNT-A) intravesical injections have been used to treat patients with refractory functional bladder disorders such as overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS), but the risk of adverse events and the need for repeated injections continue to...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2022-12-01
|
| Серія: | Toxins |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2072-6651/14/12/838 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|